Google tests healthcare ads within AI Mode
▼ Summary
– Google confirmed it is testing healthcare ads in AI Mode, limited to U.S. healthcare advertisers and English-language queries.
– The test includes campaign types like Performance Max, AI Max with search term matching, shopping, and broad match campaigns.
– Healthcare is a heavily regulated ad category, signaling Google’s approach to monetizing AI-powered search experiences.
– The initial test restricts ads from using pinned assets or text disclaimers, narrowing eligible healthcare creatives.
– Advertisers are watching for potential expansion to more healthcare advertisers, ad formats, and other regulated industries.
Google has officially confirmed it is testing healthcare advertisements within its AI Mode feature, marking a significant step in the company’s push to monetize AI-generated search results. The trial is currently limited to healthcare advertisers in the United States and applies only to English-language queries, according to Google Ads Liaison Ginny Marvin.
This confirmation follows weeks of industry chatter that healthcare ads had begun appearing inside AI-powered search experiences. The test is small in scale, but its implications are substantial for advertisers navigating one of Google’s most tightly regulated categories.
Marvin addressed the speculation on LinkedIn, stating that Google is “beginning a small test of ads in AI Mode for the healthcare vertical.” She outlined the eligible campaign types for the test, including Performance Max (PMax), AI Max with search term matching, Shopping campaigns, and broad match campaigns. Notably, these same campaign types are already eligible to serve ads within AI Overviews.
Why this matters for marketers. Healthcare advertising sits under some of the most stringent regulatory scrutiny on Google’s platform, so this test offers a crucial signal about the company’s strategy for monetizing AI-driven search. If the rollout broadens, healthcare marketers could unlock a new channel for visibility in AI Mode. Moreover, advertisers in other regulated industries might get an early glimpse into how ads will eventually appear in Google’s AI-generated results.
The initial phase comes with creative restrictions. Marvin noted that the first stage limits ads to those without pinned assets or text disclaimers, which narrows the pool of eligible healthcare creatives. This constraint may affect how advertisers craft their messaging within the AI environment.
What to watch next. The test remains small, but industry observers will be monitoring closely for signs of expansion. Key questions include whether Google will open eligibility to more healthcare advertisers, introduce additional ad formats, or extend the test to other regulated sectors. This move could also offer an early indicator of how Google plans to balance monetization with user trust as AI Mode becomes a more integral part of the search experience.
Ben Goldman, a Senior Strategist, first spotted the test and shared his findings in reply to Marvin’s GML 2026 takeaways on LinkedIn.
(Source: Search Engine Land)
